Drug discovery in post-genome era: Trend and practice

Chinese Journal of Natural Medicines

Volumn 2, Issue 5, 2004, Pages 257-260

  Chen, Kai Xian ^a   Jiang, Hua Liang ^a   Luo, Xiao Min ^a   Shen, Jian Hua ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Drug target validation; Genome; High content screening; Ligan fishing; Systems biology; Virtual screening

Indexed keywords

DRUG;

ARTICLE; BIOMEDICINE; COMPUTER SYSTEM; CONTROLLED STUDY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; INFORMATION SCIENCE; MEDICAL PRACTICE; METHODOLOGY; STRUCTURE ANALYSIS;

EID: 8644253476     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Buchdunger E, Zimmermann J, Mett H, et al . Inhibition of the abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylamino-pyrimidine derivative[J]. Canc Res, 1996,56 100-104.
2. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase ( ACE2 ) converts angiotensin I to angiotensin 1-9[J]. Circ Res. 2000,87:E1-E9.
3. Marra MA, Jones SJ, Astell CR, et al. The Genome sequence of the SARS-associated coronavirus[J]. Science, 2003, 300:1399-1404.
4. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome [J]. Science, 2003,300:1394-1399.
5. QIN ZQ, Wang J, Li W . A complete sequence and comparative analysis of a SARS-associated virus ( Isolate BJ01 ) [J]. Chin Sci Bull, 2003,48:941-948.
6. Konrad Stadler VM, Markus Eickmann Stephen Becker; Sergio Abrignani, H.-D. K. a. R. R. SARS-Beginning To Understand A New Virus[J]. Nature Reviews : Microbiology, 2003,1,209.
7. Shen X, Luo XM, Luo C, et al. Interaction Between Nucleocapsid Protein and Human Cyclopliilin A Is Associated with SARS Coronavirus Infection. (Submitted).
8. Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology[J]. Annu Rev Genomics Hum Genet, 2001,2 343-372.
9. Kitano H. Systems biology: a brief overview[J]. Science 2002,295 (5560):1662-1664.
10. Bonetta L. Systems biology - the new R&D buzzword? [J]. Nat Med. 2002,8(4):315-316.
11. Liptrot C. High content screening-from cells to data to knowledge [J]. Drug Discov Today, 2001,6(16):832-834.
12. Edwards BS, Oprea T, Prossnitz ER, et al . Flow cytometry for high-throughput, high-content screening[J]. Curr Opin Chem Biol, 2004, 8(4):392-398.
13. Drews J. Drug discovery : a historical perspective[J]. Science, 2000, 287(5460):1960-1964.
14. Doman TN, McGovern SL, Witherbee BJ, et al. Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B[J]. J Med Chem, 2002,45(11 ):2213-21.
15. (Qin ZhQ), (Zhong Y), (Zhang J), Chinese Source. (Sci Bull , 2004,49(10):948-952.